Bottom line
JDOC vs HIAHX: the short answer
JDOC (JPMorgan Healthcare Leaders ETF) and HIAHX (Hartford Healthcare Hls Fund) share a meaningful slice of their top holdings — about 62% by weight.
JDOC is cheaper at 0.65% vs 0.94% — a difference of $29 a year per $10,000 invested.
Over one year, HIAHX returned +16.1% vs +14.9% for JDOC.
Updated Nov 19, 2026
JDOC vs HIAHX side by side
| JDOC | HIAHX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | J.P. Morgan | Hartford |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.65% | 0.94% |
| Annual cost per $10k | $65 | $94 |
| 10-yr cost on $10k (prospectus) | $810 | $1,155 |
| Max front load | None | — |
| 12b-1 fee | — | 0% |
| 1-yr return | +14.9% | +16.1% |
| 5-yr return (annualized) | — | +3.5% |
| 10-yr return (annualized) | — | +7.9% |
| Best quarter | +11.3% | +21.0% |
| Worst quarter | −11.9% | −15.6% |
| Net assets (fund) | $9.1M | $112.4M |
| Number of holdings | 61 | 79 |
| Portfolio turnover | 92% | 5% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | JDOC | HIAHX | Difference |
|---|---|---|---|
| 2025 | +14.9% | +16.1% | −1.2% |
| 2024 | −0.6% | +0.4% | −1.0% |
Source: Fund prospectus bar charts
Holdings overlap
17 of JDOC's top 25 holdings also appear in HIAHX's top 25.
| Holding | JDOC | HIAHX |
|---|---|---|
| AbbVie, Inc. | 7.85% | 3.43% |
| Eli Lilly & Co. | 7.76% | 12.47% |
| UnitedHealth Group, Inc. | 5.85% | 4.72% |
| Merck & Co., Inc. | 4.82% | 6.60% |
| Johnson & Johnson | 4.82% | 6.63% |
| Thermo Fisher Scientific, Inc. | 3.73% | 1.64% |
| Abbott Laboratories | 3.11% | 2.10% |
| CVS Health Corp. | 2.83% | 2.93% |
| GSK plc | 2.47% | 1.21% |
| Stryker Corp. | 2.23% | 1.17% |
| Danaher Corp. | 2.16% | 2.65% |
| Cencora, Inc. | 2.07% | 2.07% |
| Intuitive Surgical, Inc. | 1.93% | 2.99% |
| Edwards Lifesciences Corp. | 1.73% | 2.42% |
| Regeneron Pharmaceuticals, Inc. | 1.60% | 1.52% |
Source: SEC Form N-PORT
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
HIAHX top 10
- Eli Lilly & Co — 12.47%
- Johnson & Johnson — 6.63%
- Merck & Co Inc — 6.60%
- UnitedHealth Group Inc — 4.72%
- AbbVie Inc — 3.43%
- Intuitive Surgical Inc — 2.99%
- Elevance Health Inc — 2.96%
- CVS Health Corp — 2.93%
- Vertex Pharmaceuticals Inc — 2.69%
- Danaher Corp — 2.65%
FAQ
What is the difference between JDOC and HIAHX?
Which is cheaper, JDOC or HIAHX?
Should I own both JDOC and HIAHX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.